@article{JGO15305,
author = {Alfonso García-Fadrique and Akash Mehta and Faheez Mohamed and Sanjeev Dayal and Tom Cecil and Brendan J. Moran},
title = {Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review},
journal = {Journal of Gastrointestinal Oncology},
volume = {8},
number = {5},
year = {2017},
keywords = {},
abstract = {Peritoneal mesothelioma (PM) is an uncommon but a serious, and often, fatal primary peritoneal tumour, with increasing incidence worldwide. Conventional systemic chemotherapy, generally based on experience with pleural mesothelioma, usually has disappointing results considering PM as a terminal condition. Patients usually present with non-specific symptoms of abdominal distension and pain making the diagnosis challenging. As PM is confined to the abdomen for all, or much, of its clinical course, a multimodality treatment combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a new standard of care, and has been reported to achieve promising survival outcomes and local disease control in selected patients with PM. This review updates the presentation, diagnosis, classification and treatment strategies for PM.},
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/15305}
}